title: 153 Samarium-EDTMP in myeloablative dosage followed by a second autotransplantation in patients with relapsed multiple myeloma.
authors.affiliation: Dept. of Hematology and Oncology, Tuebingen University Hospital, Tuebingen, German. stefan.knop@med.uni-tuebingen.de
authors.forename: Stefan
authors.initials: S
authors.lastname: Knop
authors.forename: Bernhard M
authors.initials: BM
authors.lastname: Dohmen
authors.forename: Lothar
authors.initials: L
authors.lastname: Kanz
authors.forename: Roland
authors.initials: R
authors.lastname: Bares
authors.forename: Hermann
authors.initials: H
authors.lastname: Einsele
mesh_terms: D017809:Fatal Outcome; D006085:Graft Survival; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000150:complications / Q000532:radiotherapy* / Q000601:surgery; D009942:Organometallic Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use*; D009943:Organophosphorus Compounds / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010014:Osteolysis / Q000209:etiology / Q000532:radiotherapy; D036102:Peripheral Blood Stem Cell Transplantation; D011868:Radioisotopes / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016879:Salvage Therapy; D012493:Samarium / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019172:Transplantation Conditioning; D014182:Transplantation, Autologous; D016896:Treatment Outcome
chemical_list: D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; D011868:Radioisotopes; D019275:Radiopharmaceuticals; C018940:(ethylenedinitrilo)-tetramethylenephosphonic acid; D012493:Samarium; C061972:samarium Sm-153 lexidronam; D008558:Melphalan